April 6, 2020 BARRON’S 31
INCOME INVESTING
To preserve capital for its dividend,Chevron has
cut 2020 capital spending by 20%, to $16 billion.
Its stock recently yielded 7.2%
These 8 Aristocrats
Have Safe Dividends.
(Safe Being Relative.)
A
s dozens of compa-
nies have cut or sus-
pended dividends in
recent weeks to pre-
serve cash amid the
uncertain impact of
the coronavirus pan-
demic on the economy, the deteriorat-
ing payout picture has become a fa-
miliar refrain in this column.
Where, then, to turn when nothing
is a given?
Barron’s started with the S&P 500
Dividend Aristocrats, which have
raised their dividends for at least 25
straight years, for ideas. The group
has 64 members, and with the help of
FactSet data, we whittled it down to
eight that appear to have some bul-
wark to maintain their dividends, as
the accompanying table shows. (There
soon will be 66 Aristocrats due to
United Technologies (ticker: UTX)
merging with non-Aristocrat Ray-
theon (RTN) and two companies be-
ing spun out.)
The criteria for our list included a
net debt (debt minus cash) to earnings
before interest, taxes, depreciation,
and amortization (Ebitda) ratio below
2, a reasonable level. We also looked
for companies with debt-to-capital
ratios below 40% and an increase in
free cash flow in recent years. (The
data cover the companies’ three most
recent fiscal years.)
The working assumption for those
criteria is that the less leveraged a
company is, the better for dividend
safety, especially as a steep recession
looms. A more subjective criterion
was to focus on businesses that ap-
pear to have a relative advantage to
maintain their operations and divi-
dends during the pandemic—selling
toilet paper, coronavirus testing kits,
or generating fees from assets under
management, for example.
Of course, past isn’t prologue, partic-
ularly since this exercise is occurring
against a backdrop in which dividends
are under pressure from a pandemic
with no modern precedent. Even indus-
tries that have been traditional dividend
havens, such as staples and utilities,
pose risks for income-oriented inves-
tors looking for increases. “They al-
ready have high payout ratios and are
unlikely to lift them further,” says To-
bias Levkovich, chief U.S. equity strate-
gist at Citigroup Global Markets.
But if a company maintains its divi-
dend in this environment, it’s a victory.
From now until the crisis abates, pay-
out increases are much less likely.
Levkovich expects the S&P 500’s
earnings to drop 24% this year and
dividends to fall by 30%. The energy
sector, he says, is “front and center on
cutting payouts” as the economy craters
and oil prices plummet, as Saudi Ara-
bia and Russia engage in a price war.
Yet our list of durable Aristocrats
includes Chevron (CVX), one of the
biggest energy companies. That’s be-
cause Chevron CEO Mike Wirth, in a
recent interview with Barron’s , said
the company will use its balance sheet
to protect the dividend. “We have one
of the strongest balance sheets in the
industry,” Wirth says. “We can use it
when we need it.” That could include
taking on more debt or selling assets,
if needed, to maintain the payout.
To preserve capital, the giant en-
ergy firm has already suspended stock
buybacks and slashed 2020 capital
spending by 20%, to $16 billion. The
company has raised its dividend for
more than 30 years. The stock’s yield
was recently 7.2%, the highest among
the field of eight.
Our list also includes Procter &
Gamble (PG) and Kimberly-Clark
(KMB), both of which sell a lot of con-
sumer products. Their yields were
recently 2.7% and 3.3%, respectively.
Procter’s brands include Bounty
paper towels, Puffs tissues, and
Charmin toilet paper, key products
that consumers covet right now as
they hunker down in their homes. The
company has increased its payout for
63 straight years. Kimberly Clark’s
brands include Kleenex and Cottonelle
toilet paper. It has raised its dividend
for 47 consecutive years.
Levkovich notes that it’s important
to look at average sector payout ratios,
which measure the percentage of
earnings paid out as dividends. Tech-
nology is around 30% and health care
was at about 35% at the end of 2019.
That, in theory at least, gives cer-
tain companies in those sectors room
to raise their payouts, “but we wonder
if they will, under the current back-
drop,” Levkovich says.
The three health-care firms on the
list include Medtronic (MDT), whose
many medical devices include ventila-
tors—a crucial piece of equipment as
the pandemic widens and hospitals
need them in increasing numbers. The
stock was recently yielding 2.4%, and
the company has raised its dividend
for 42 years in a row.
Another health-care product maker,
Johnson & Johnson (JNJ), has a
strong balance sheet and AAA credit
rating—one of the few companies with
that distinction. J&J said on March 30
that it could have a Covid-19 vaccine
available for emergency use early next
year, a potential long-term boon for its
shares. The stock’s recent yield was
2.9%, and the company has boosted its
dividend for 57 straight years.
Meanwhile, Abbott Laboratories
(ABT) recently received emergency
approval from the U.S. Food and Drug
Administration for a Covid-19 test that
takes as little as five minutes. The stock
was recently yielding 1.8%, the lowest
on the list, and Abbott has increased its
payout for 47 consecutive years.
Rounding out our list are Hormel
Foods (HRL) and asset manager T.
Rowe Price (TROW). Hormel, whose
products include comfort foods that
could appeal to home-bound consum-
ers, has raised its dividend for 54 years
in a row; T. Rowe Price has reached the
34-year mark. They yield 2% and 3.7%,
respectively. Neither has a heavy debt
load, something that should help them
weather this downturn with their pay-
outs intact, if not rising.
Bottom line: Nothing is certain, so
long as the coronavirus pandemic
rages on, but these Aristocrats come
as close to a safe bet as possible.B
By Lawrence C.
Strauss
Durable Aristocrats
Among the 64 S&P 500 Dividend Aristocrats, the dividends of these eight stocks look safe for now, thanks in part
to relatively low debt loads.
Recent Market YTD Dividend
Company /Ticker Price Value (bil) Return Yield Industry
Abbott Laboratories /ABT $79.05 $139.9 -8.7% 1.8% Health care products
Chevron /CVX 71.46 135.2 -39.0 7.2 Energy
Hormel Foods /HRL 46.54 25.2 4.1 2.0 Meat/Fish/Dairy
Johnson & Johnson /JNJ 131.27 350.7 -9.4 2.9 Pharmaceuticals/Health care
Kimberly-Clark /KMB 127.74 45.2 -6.2 3.3 Household/Personal care
Medtronic /MDT 90.22 123.4 -19.8 2.4 Medical devices
Procter & Gamble /PG 110.02 284.0 -11.5 2.7 Household/Personal care
T. Rowe Price Group /TROW 97.71 23.1 -19.1 3.7 Asset management
Data as of March 31 Source: FactSet